A benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosis.

"Declarations Ethics approval and consent to participateThis study was performed in accordance with the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of Nanjing Chest Hospital. Written informed consent was obtained from all participants. The ethical approval number was 2021-KL025-01. Consent for publicationNot applicable. Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."

"Funding This work was supported by Scientific Research Project of Cancer Foundation of China (grant number CFC-XGB-202201), Clinical Research Fund of Wu Jieping Medical Foundation (grant number 320.6750.2020-10-27), the CSCO-Shiyao Tumor Research Fund (grant number Y-SY201901-0056), and the CSCO-Junshi Tumor Immunology Research Fund (grant number Y-JS2019-017)."